Cargando…

Effectiveness of long-term (twelve months) nonsurgical weight loss interventions for obese women with polycystic ovary syndrome: a systematic review

Polycystic ovary syndrome (PCOS) affects 2%–26% of women of reproductive age and is often accompanied by obesity. Modest weight loss reduces health risks and ameliorates effects of the syndrome. Weight loss interventions are mainly of short duration and have limited success. A systematic review of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nicholson, Fiona, Rolland, Catherine, Broom, John, Love, John
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990909/ https://www.ncbi.nlm.nih.gov/pubmed/21151687 http://dx.doi.org/10.2147/IJWH.S13456

Ejemplares similares

The experiences of women with polycystic ovary syndrome on a very low-calorie diet
por: Love, John G, et al.
Publicado: (2016)

Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks
por: Nikokavoura, Efsevia A, et al.
Publicado: (2015)

Effect of weight loss on adipokine levels in obese patients
por: Rolland, Catherine, et al.
Publicado: (2011)

Economic value of nonsurgical weight loss in adults with obesity
por: Ding, Yuchen, et al.
Publicado: (2021)

The Impact of COVID-19 Lockdown on Weight Loss Program in Infertile Polycystic Ovary Syndrome Women with Obesity
por: Šuštaršič, Ana, et al.
Publicado: (2021)

Gut Microbiota Patterns Predicting Long-Term Weight Loss Success in Individuals with Obesity Undergoing Nonsurgical Therapy
por: Bischoff, Stephan C., et al.
Publicado: (2022)

Predictors of Lifestyle Intervention Attrition or Weight Loss Success in Women with Polycystic Ovary Syndrome Who Are Overweight or Obese
por: Moran, Lisa J., et al.
Publicado: (2019)

The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
por: Rasmussen, Christina B., et al.
Publicado: (2014)

Lifestyle treatment in women with polycystic ovary syndrome: predictors of weight loss and dropout
por: Jiskoot, Geranne, et al.
Publicado: (2022)

Quality of life in overweight (obese) and normal-weight women with polycystic ovary syndrome
por: Panico, Annalisa, et al.
Publicado: (2017)

Different sleep pattern in over-weight/obese women with polycystic ovary syndrome
por: Oberg, Emma, et al.
Publicado: (2023)

Effect of GLP-1 agonists on weight loss in patients with polycystic ovary syndrome and obesity: A single-center study
por: Srinivasan, Dushyanth, et al.
Publicado: (2022)

Evidence of nonsurgical treatment for polycystic liver disease
por: Yoo, Jeong-Ju, et al.
Publicado: (2022)

Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
por: Jensterle Sever, Mojca, et al.
Publicado: (2014)

Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome
por: Cheang, Kai I., et al.
Publicado: (2016)

Visfatin and Resistin Serum Levels in Normal-Weight and Obese Women With Polycystic Ovary Syndrome
por: Farshchian, Fatemeh, et al.
Publicado: (2014)

Why are women with polycystic ovary syndrome obese?
por: Barber, T M
Publicado: (2022)

Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss
por: Dawson, Alison J., et al.
Publicado: (2017)

Effect of Weight Maintenance on Symptoms of Knee Osteoarthritis in Obese Patients: A Twelve-Month Randomized Controlled Trial
por: Christensen, Robin, et al.
Publicado: (2015)

Short-term effect of beinaglutide combined with metformin versus metformin alone on weight loss and metabolic profiles in obese patients with polycystic ovary syndrome: a pilot randomized trial
por: Wen, Qing, et al.
Publicado: (2023)

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
por: Moran, Carlos, et al.
Publicado: (2012)

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
por: Kahal, Hassan, et al.
Publicado: (2011)

Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
por: López-Alarcón, Mardia, et al.
Publicado: (2023)

Insights into Manipulating Postprandial Energy Expenditure to Manage Weight Gain in Polycystic Ovary Syndrome
por: Siemienowicz, Katarzyna, et al.
Publicado: (2020)

Evaluation of a multiprofessional, nonsurgical obesity treatment program: which parameters indicated life style changes and weight loss?
por: Pjanic, et al.
Publicado: (2017)

Effects of serum irisin, neuregulin 4, and weight management on obese adolescent girls with polycystic ovary syndrome
por: Cao, Shunshun, et al.
Publicado: (2021)

Case of Amaurosis of Both Eyes, of Twelve Months Standing
por: Rheineck, H. John, et al.
Publicado: (1816)

Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome
por: Ma, Rui-Lin, et al.
Publicado: (2021)

Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease
por: Steele, Cortney, et al.
Publicado: (2022)

Obesity and Outcome of Assisted Reproduction in Patients With Polycystic Ovary Syndrome
por: Tziomalos, Konstantinos, et al.
Publicado: (2018)

Prohibitin-induced obesity leads to anovulation and polycystic ovary in mice
por: Ande, Sudharsana Rao, et al.
Publicado: (2017)

Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
por: Zhou, Jiaojiao, et al.
Publicado: (2021)

Erratum to: Evaluation of a multiprofessional, nonsurgical obesity treatment program: which parameters indicated life style changes and weight loss?
por: Pjanic, Irena, et al.
Publicado: (2017)

Delta neutrophil index in obese and non-obese polycystic ovary syndrome patients
por: Günday, Özlem Kayacık, et al.
Publicado: (2023)

Insulin resistance and adverse metabolic profile in overweight/obese and normal weight of young women with polycystic ovary syndrome
por: Gholinezhad, Maryam, et al.
Publicado: (2018)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Heart rate variability in normal-weight patients with polycystic ovary syndrome
por: Kilit, Celal, et al.
Publicado: (2017)

Heart rate variability in normal-weight patients with polycystic ovary syndrome
por: Perini, Renza
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g70776a2qm003prl9tp4uhreus